HLA-C and neoplasm: While MHC-I is important for the recognition of tumor cells by cytotoxic T lymphocytes [8], MHC-Ilow/neg tumor cells are susceptible to lysis by natural killer (NK) cells, innate immune cells that lyse malignant cells by releasing lytic granules and engaging death receptors [9].